Tofacitinib is associated with attainment of the minimally important reduction in axial magnetic resonance imaging inflammation in ankylosing spondylitis patients

Walter P. Maksymowych, Désirée Van Der Heijde, Xenofon Baraliakos, Atul Deodhar, Sarah P. Sherlock, David Li, Dona Fleishaker, Thijs Hendrikx, Keith S. Kanik

Research output: Contribution to journalArticlepeer-review

43 Scopus citations

Fingerprint

Dive into the research topics of 'Tofacitinib is associated with attainment of the minimally important reduction in axial magnetic resonance imaging inflammation in ankylosing spondylitis patients'. Together they form a unique fingerprint.

Medicine & Life Sciences